Radio-Immunotherapy (RIT): Long-term Follow-up Results with I-131 Labeled Antibody in 52 Patients with Non-Hodgkin's Lymphoma (NHL) Refractory to Chemotherapy and Rituxan

Author(s):  
J.B. Colenda ◽  
R. Mark ◽  
P. Anderson ◽  
T. Neumann ◽  
M. Nair ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document